Mangrove Partners has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $778 Million distributed in 178 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Rio Tinto PLC with a value of $65.9M, Enova International, Inc. with a value of $57.2M, Ecovyst Inc. with a value of $48M, Teva Pharmaceutical Industries LTD with a value of $47.2M, and Open Text Corp with a value of $39.3M.

Examining the 13F form we can see an increase of $87.8M in the current position value, from $691M to 778M.

Mangrove Partners is based out at New York, NY

Below you can find more details about Mangrove Partners portfolio as well as his latest detailed transactions.

Portfolio value $778 Million
Healthcare: $175 Million
Basic Materials: $135 Million
Technology: $119 Million
Financial Services: $75 Million
Consumer Defensive: $72.7 Million
Utilities: $50.6 Million
Consumer Cyclical: $40.1 Million
Communication Services: $39.4 Million
Other: $35.4 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 178
  • Current Value $778 Million
  • Prior Value $691 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 111 stocks
  • Additional Purchases 36 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.